Search

Your search keyword '"Messas E"' showing total 503 results
Start Over Author "Messas E"
503 results on '"Messas E"'

2. Non-invasive Evaluation of Aortic Stiffness Dependence with Aortic Blood Pressure and Internal Radius by Shear Wave Elastography and Ultrafast Imaging

Author

Papadacci, Clement, Mirault, T., Dizier, B., Tanter, M., Messas, E., and Pernot, M.

Subjects
Physics - Medical Physics
Abstract

Elastic properties of arteries have long been recognized as playing a major role in the cardiovascular system. However, non-invasive in vivo assessment of local arterial stiffness remains challenging and imprecise as current techniques rely on indirect estimates such as wall deformation or pulse wave velocity. Recently, Shear Wave Elastography (SWE) has been proposed to non-invasively assess the intrinsic arterial stiffness. In this study, we applied SWE in the abdominal aortas of rats while increasing blood pressure (BP) to investigate the dependence of shear wave speed with invasive arterial pressure and non-invasive arterial diameter measurements. A 15MHz linear array connected to an ultrafast ultrasonic scanner, set non-invasively, on the abdominal aorta of anesthetized rats (N=5) was used. The SWE acquisition followed by an ultrafast (UF) acquisition was repeated at different moment of the cardiac cycle to assess shear wave speed and arterial diameter variations respectively. Invasive arterial BP catheter placed in the carotid, allowed the accurate measurement of pressure responses to increasing does of phenylephrine infused via a venous catheter. The SWE acquisition coupled to the UF acquisition was repeated for different range of pressure. For normal range of BP, the shear wave speed was found to follow the aortic BP variation during a cardiac cycle. A minimum of (5.06$\pm$0.82) m/s during diastole and a maximum of (5.97$\pm$0.90) m/s during systole was measured. After injection of phenylephrine, a strong increase of shear wave speed (13.85$\pm$5.51) m/s was observed for a peak systolic arterial pressure of (190$\pm$10) mmHg. A non-linear relationship between shear wave speed and arterial BP was found. A complete non-invasive method was proposed to characterize the artery with shear wave speed combined with arterial diameter variations. Finally, the results were validated against two parameters the incremental elastic modulus and the pressure elastic modulus derived from BP and arterial diameter variations.

Published
2019
Full Text
View/download PDF

3. Clinical outcomes in patients in any phase of CML treated with ponatinib in France—Data from the TOPASE observational study.

Author

Huguet, F., Guerci‐Bresler, A., Roth‐Guepin, G., Cayssials, E., Slama, B., Santagostino, A., Penot, A., Quittet, P., Cony‐Makhoul, P., Saad, A., Bastie, J. N., Hacini, M., Coiteux, V., Uzunov, M., Roy, L., Le Clech, L., Berger, M., Agneray, A. M., Messas, E., and Etienne, G.

Abstract

Summary: The TOPASE study was set up to evaluate the outcomes of chronic myeloid leukaemia [CML] patients treated with ponatinib (PON) in a real‐world setting in France. One hundred and twenty CML patients, 105 in chronic phase (CP), 8 in accelerated phase (AP) and 7 in blastic phase (BP) were included. Fifty‐one (49%) of the CP‐CML patients were in third line of treatment. The trigger for PON initiation in CP‐CML was 'poor response' in 67 patients, 'poor tolerance' in 28 patients and 'response enhancement' in seven patients. The median dose at initiation was 30 mg/day [Q1; Q3 = 15; 30] in CP‐CML and 45 mg/day [Q1; Q3 = 30; 45] in AP/BP‐CML. Of 98 CP‐CML evaluable patients, 72 (73.5%) were considered as responders (MMR) at one time point at least once, especially for those in second line of treatment and/or presenting a T315I mutation. Ninety‐six of 120 (80%) patients reported at least one adverse event. An arterial occlusive event (AOE) was reported in 11 patients (9.2%). Thus, these real‐life data confirm the potency of ponatinib in resistant or intolerant patients with an acceptable safety profile in non‐selected patients. NCT number: NCT04048564. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC)

Author

Rafii, H., Frère, C., Benzidia, I., Crichi, B., Andre, T., Assenat, E., Bournet, B., Carpentier, A., Connault, J., Doucet, L., Durant, C., Emmerich, J., Gris, J.C., Hij, A., Le Hello, C., Madelaine, I., Messas, E., Ndour, A., Villiers, S., Marjanovic, Z., Ait Abdallah, N., Yannoutsos, A., and Farge, D.

Published
2020
Full Text
View/download PDF

14. Novel Association of the NOTCH Pathway Regulator MIB1 Gene With the Development of Bicuspid Aortic Valve.

Author

Tessler, I., Albuisson, J., Piñeiro-Sabarís, R., Verstraeten, A., Kamber Kaya, H.E., Siguero-Álvarez, M., Goudot, G., MacGrogan, D., Luyckx, I., Shpitzen, S., Levin, G., Kelman, G., Reshef, N., Mananet, H., Holdcraft, J., Muehlschlegel, J.D., Peloso, G.M., Oppenheim, O., Cheng, C., Mazzella, J.M., Andelfinger, G., Mital, S., Eriksson, P., Billon, C., Heydarpour, M., Dietz, H.C., Jeunemaitre, X., Leitersdorf, E., Sprinzak, D., Blacklow, S.C., Body, S.C., Carmi, S., Loeys, B.L., Pompa, J.L. de la, Gilon, D., Messas, E., Durst, R., Tessler, I., Albuisson, J., Piñeiro-Sabarís, R., Verstraeten, A., Kamber Kaya, H.E., Siguero-Álvarez, M., Goudot, G., MacGrogan, D., Luyckx, I., Shpitzen, S., Levin, G., Kelman, G., Reshef, N., Mananet, H., Holdcraft, J., Muehlschlegel, J.D., Peloso, G.M., Oppenheim, O., Cheng, C., Mazzella, J.M., Andelfinger, G., Mital, S., Eriksson, P., Billon, C., Heydarpour, M., Dietz, H.C., Jeunemaitre, X., Leitersdorf, E., Sprinzak, D., Blacklow, S.C., Body, S.C., Carmi, S., Loeys, B.L., Pompa, J.L. de la, Gilon, D., Messas, E., and Durst, R.

Abstract

Contains fulltext : 295944.pdf (Publisher’s version ) (Closed access), IMPORTANCE: Nonsyndromic bicuspid aortic valve (nsBAV) is the most common congenital heart valve malformation. BAV has a heritable component, yet only a few causative genes have been identified; understanding BAV genetics is a key point in developing personalized medicine. OBJECTIVE: To identify a new gene for nsBAV. DESIGN, SETTING, AND PARTICIPANTS: This was a comprehensive, multicenter, genetic association study based on candidate gene prioritization in a familial cohort followed by rare and common association studies in replication cohorts. Further validation was done using in vivo mice models. Study data were analyzed from October 2019 to October 2022. Three cohorts of patients with BAV were included in the study: (1) the discovery cohort was a large cohort of inherited cases from 29 pedigrees of French and Israeli origin; (2) the replication cohort 1 for rare variants included unrelated sporadic cases from various European ancestries; and (3) replication cohort 2 was a second validation cohort for common variants in unrelated sporadic cases from Europe and the US. MAIN OUTCOMES AND MEASURES: To identify a candidate gene for nsBAV through analysis of familial cases exome sequencing and gene prioritization tools. Replication cohort 1 was searched for rare and predicted deleterious variants and genetic association. Replication cohort 2 was used to investigate the association of common variants with BAV. RESULTS: A total of 938 patients with BAV were included in this study: 69 (7.4%) in the discovery cohort, 417 (44.5%) in replication cohort 1, and 452 (48.2%) in replication cohort 2. A novel human nsBAV gene, MINDBOMB1 homologue MIB1, was identified. MINDBOMB1 homologue (MIB1) is an E3-ubiquitin ligase essential for NOTCH-signal activation during heart development. In approximately 2% of nsBAV index cases from the discovery and replication 1 cohorts, rare MIB1 variants were detected, predicted to be damaging, and were significantly enriched compared with populati

Published
2023

18. Place of the Advanced Practice Registered Nurse (APRN) within the vascular team: A qualitative study of vascular medicine physicians and nurses caring for patients with Peripheral Artery Disease (PAD)

Author

Kubiak, T., primary, Sitruk, J., additional, Mortelette, H., additional, Durivage, A., additional, Mohamedi, N., additional, Détriché, G., additional, Khider, L., additional, Messas, E., additional, Mirault, T., additional, and Goudot, G., additional

Published
2023
Full Text
View/download PDF

20. Fluoroquinolone use preceding medium-size artery dissection: A case series

Author

Wang, L., primary, Oehmichen, B., additional, Pariente, B., additional, Mohamedi, N., additional, Cheng, C., additional, Détriché, G., additional, Galloula, A., additional, Khider, L., additional, Lillo Le Louet, A., additional, Messas, E., additional, Amar, L., additional, Goudot, G., additional, and Mirault, T., additional

Published
2023
Full Text
View/download PDF

31. EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT)

Author

Komajda, Michel, Weidinger, Franz, Kerneis, Mathieu, Cosentino, Francesco, Cremonesi, Alberto, Ferrari, Roberto, Kownator, Serge, Steg, Philippe Gabriel, Tavazzi, Luigi, Valgimigli, Marco, Szwed, Hanna, Majda, Wojciech, Olivari, Zoran, Van Belle, Eric, Shlyakhto, Evgeny Vladimirovich, Mintale, Iveta, Slapikas, Rimvydas, Rittger, Harald, Mendes, Miguel, Tsioufis, Constantinos, Balanescu, Serban, Laroche, Cécile, Maggioni, Aldo Pietro, Komajda, Michel, Weidinger, Franz, Cosentino, Francesco, Cremonesi, Alberto, Ferrari, Roberto, Kownator, Serge, Maggioni, Aldo P., Steg, Gabriel, Tavazzi, Luigi, Valgimigli, Marco, Balanescu, Serban, Mendes, Miguel, Mintale, Iveta, Olivari, Zoran, Rittger, Harald, Shlyakhto, Evgeny V., Slapikas, Rimvydas, Szwed, Hanna, Van Belle, Éric, Laroche, Cécile, McNeill, Patti-Ann, Ferreira, Thierry, Vochelet, F., Tavildari, A., Silvestri, M., Maillard, L., Sevilla, J., Malaquin, D., Leborgne, L., Fournier, A., Jarry, G., Teiger, E., Marchant, B., Van Belle, E., Criquioche, A., Dupouy, P., Madiot, H., Lafitte, B., Belle, L., Cayla, G., Abouth-Benamara, S., Messas, E., Delarche, N., Bouvier, E., Couleru, J., Paparoni, F., Marchant, B., Bedossa, M., Lepage, Q., Le Bouquin, L., Auffret, V., Leurent, G., Boulmier, D., Le Breton, H., Vidal, C., Touet, M., Tron, C., Hemmerling, S., Flugel, P.-C., Beschorner, U., Noory, E., Strubin, J., Macharzina, R., Lindemann, C., Specht, T., Brantner, R., Zeller, T., Schwarzwalder, U., Hirschmann, S., Schonhardt, S., Slimack-Braun, S., Link, S., Hauk, M., Welslau, M., Henning, A., Menz, C., Buciuceanu, V., Rastan, A., Bschorr, R., Schmitt, C., Maas, C., Jacques, B., Bohme, T., Burgelin, K., Hoffmann, M., Pirzer, R., Brune, M., Braun, M., Stolte, D., Dietrich, A., Singh, A., Rittger, H., Schibgilla, V., Hopf, S., Fouridis, P., Fabiani, R., Jakob, A., Garlichs, C., Trautvetter, J., Schineis, N., Brugger, A., Bojanic, D., Matschke, C., Schmidt, A., Scheinert, D., Scheinert, S., Banning-Eichenseer, U., Stauffer, A., Straube, F., Hoffmann, E., Antoni, D., Rieber, J., Tomelden, J., Deichstetter, M., Landwehr, P., Reif, S., Kallikazaros, I., Tsioufis, C., Korkovili, M., Stamatelopoulos, K., Tsoumani, Z., Loizos, S., Kanakakis, I., Kampouridis, N., Simeonidis, D., Bougas, T., Chasapi, A., Alexopoulos, D., Xanthopoulou, I., Vogiatzi, X., Stavrou, K., Bampouri, T., Sicuro, M., Amato, G., Pisano, F., Casolati, D., Bare, C., Grotti, S., Angioli, P., Bolognese, L., Ducci, K., Porto, I., Falsini, G., Liisto, F., Manzi, R.C., Langiu, M., Lai, C., Lodolini, V., Biscaglia, S., Ferrari, R., Occhilupo, P., Tebaldi, M., Minarelli, M., Fileti, L., Campo, G., Sbarzaglia, P., Bonilla, N., Schiavina, G., dʼAlessandro, G., Borghesi, M., Cremonesi, A., Rota, I., Ghigliotti, G., Davi, F., Beccaria, F., Brunelli, C., Mussardo, M., Cisotta, F., Spagnolo, B., Liso, A., Dal Corso, L., Favretto, G., Borsatto, F., Benedetto, M., Cirrincione, G., Gandolfo, C., Caruso, M., Stabile, A., Lanteri, S., Riina, M., Lunetto, M.L., Vadala, G., Micari, A., Rossi, E., Griksteite, E., Cavallini, C., Longhi, S., Pasqualini, M., Negrelli, M., Pacchioni, E., Brunazzi, M.C., Marcomin, C., Neri, R., Cassin, M., Vendrametto, F., Macor, F., Nicolosi, G., Pavan, D., Piasentin, C., Roman-Pognuz, A., Taccheri, T., Calcagno, S., Pagliaro, M., Mancone, M., Fedele, F., Cinque, A., Armato, A., Tarducci, R., Della Bona, R., Brandini, R., Rossi, P., Fronticelli, M., Casavecchia, M., Olivari, Z., Calzolari, D., Daniotti, A., Balcere, K., Stirna, V., Libins, A., Zabunova, M., Silina, E., Ozola, G., Rancane, G., Babarskiene, R., Viezelis, M., Petrauskaite, J., Rumbinaite, E., Stankala, S., Juszczyk, Z., Karwowska Polecka, W., Oleksza, A., Bialek, P., Klimczuk, A., Poplawski, A., Aksiucik, A., Musial, W., Swiecki, P., Marcinkiewicz-Siemion, M., Ptaszynska-Kopczynska, K., Prokop, J., Kubica, J., Janiszewska, E., Kopczynska, A., Tarnawska, M., Gruchala, M., Pajkowski, M., Raczak, G., Wojtowicz, D., Strozyk, A., Miekus, P., Szyman, M., Glaza, M., Roszko-Grycner, E., Szpajer, M., Wroblewska, M., Zadrozny, J., Muller, H., Puzio, E., Lesinski, D., Borowski, B., Kowalska, A., Wojtyniak, I., Krzewinska, J., Borej, G., Czaja, P., Janion, M., Zandecki, L., Kuczerowska, R., Bogacki, P., Kafara, M., Rola, A., Podolec, P., Waligora, M., Brozda, M., Skrzynska, M., Glowa, B., Gawor, Z., Dejak, P., Brylka, A., Banasiak, M., Simiera, M., Krecki, R., Ojrzanowski, M., Jankowski, L., Kupczynska, K., Kasprzak, J.D., Zapolski, T., Zarczuk, R., Lukasik, D., Wysokinski, A., Zalewska-Nowak, G., Tarnolicki, M., Major, M., Gorny, J., Krzyzanowski, W., Muzyk-Osikowicz, M., Boltryk, K., Grajek, S., Maczynski, M., Lesiak, M., Komosa, A., Drewnicki, A., Wolniewicz, L., Komorowska, E., Gmyrek, N., Kowalik, M., Kostka, M., Kaminski, L., Mikolowicz-Mosiadz, A., Mazur, R., Kosztowniak, M., Pajaczkowski, K., Duda, K., Kosno-Zak, J., Dworak-Podlewska, E., Burchard, E., Wrzosek, B., Gurba, S., Wozniak, P., Dabek, M., Kuzniar, J., Lyczywek, M., Szubielski, M., Gajewski, M., Wasiak, D., Oscik-Lukasiewicz, M., Kawka-Urbanek, T., Diks, F., Przywoska-Para, B., Drazkowicz-Gozdzik, B., Kornacewicz-Jach, Z., Kula, L., Goracy, J., Chlasta, J., Tomaniak, M., Opolski, G., Serafin, A., Pietrasik, A., Kosek, M., Jastrzebski, J., Witkowski, A., Pruszczyk, P., Roik, M., Kostrubiec, M., Irzyk, K., Wretowski, D., Labyk, A., Budaj, A., Maciejewski, P., Szwed, H., Majda, W., Chojecka, M., Mosur, M., Gajer-Blaszczyk, K., Bociaga, Z., Loboz-Rudnicka, M., Loboz-Grudzien, K., Jaroch, J., Rzyczkowska, B., Chelstowski, W., Lewandowska, A., Darocha, A., Skowron, W., Polonski, L., Maciol-Skurk, K., Madeira, S., Mendes, M., Brito, J., Santos, M., Leite, L., Vicente, J., Calisto, J., Faria, H., Jorge, E., Mendes, A., Santos, R., Pinto, P., Guedes, H., Placido, R., Correia, M.J., Cabrita, I., Rodrigues, C., Nunes Diogo, A., Magalhaes, A., Canas da Silva, A., Selas, M., Portugal, G., Viveiros Monteiro, A., Timoteo, A.T., Ribeiro, M., Espregueira Mendes, D., Rodrigues, R., Lopes, R., Ribeiro, V., Melao, F., Magalhaes, D., Silva, J., Ribeiro, V. Gama, Braga, P., Goncalves, M., de Morais, G. Pires, Melica, B., Rodrigues, A., Santos, L., Cojocaru, L., Mazilu, L., Suceveanu, A.I., Rusali, A., Parepa, I.R., Maxim, R., Matei, L., Ioanovici, S., Buzas, R., Mihaela Iuliana, M., Susan, M., Ionita, M., Coceala, L., Suceava, I., Ciobotaru, G., Lighezan, D., Nicolescu, C., Mukhametgatova, D., Baleeva, L., Galyavich, A., Gratsiansky, N.A., Erlikh, A., Kondratenko, V., Libis, R., Vezikova, N., Skopets, I., Marusenko, I., Lapshin, K., Yakovlev, A., Lokhovinina, N., Alugishvili, M., Panov, A., Abesadze, I., Salakhova, J., Kondrateva, I., and Duplyakov, D.

Published
2016
Full Text
View/download PDF

34. Carotid plaque vulnerability assessed by combined shear wave elastography and ultrafast doppler compared to histology: the UF-plaque study

Author

Goudot, G, primary, Sitruk, J, additional, Jimenez, A, additional, Khider, L, additional, Julia, P, additional, Alsac, J M, additional, El Batti, S, additional, Bruneval, P, additional, Amemyia, K, additional, Pedreira, O, additional, Calvet, D, additional, Tanter, M, additional, Mirault, T, additional, Pernot, M, additional, and Messas, E, additional

Published
2021
Full Text
View/download PDF

36. Impact des antagonistes des récepteurs de l’angiotensine II sur la mortalité après hospitalisation pour artériopathie athéromateuse des membres inférieurs symptomatique : une étude prospective du registre COPART

Author

Lapébie, F.X., primary, Bura-Rivière, A., additional, Lacroix, P., additional, Constans, J., additional, Boulon, C., additional, Messas, E., additional, Aboyans, V., additional, Ferrières, J., additional, and Bongard, V., additional

Published
2021
Full Text
View/download PDF

39. Copy number variation analysis in bicuspid aortic valve-related aortopathy identifies TBX20 as a contributing gene

Author

Luyckx, I, Kumar, AA, Reyniers, E, Dekeyser, E, Vanderstraeten, K, Vandeweyer, G, Wunnemann, F, Preuss, C, Mazzella, JM, Goudot, G, Messas, E, Albuisson, J, Jeunemaitre, X, Eriksson, P, Mohamed, SA, Kempers, M, Salemink, S, Duijnhouwer, A, Andelfinger, G, Dietz, HC, Verstraeten, A (Aline), Van Laer, L, Loeys, BL, Zhurayev, R, Zerbino, D, Mital, S, Mertens, L, Franco-Cereceda, A, Verhagen, Judith, De Graaf - van de Laar, Ingrid, Wessels, Marja, Nemcikova, M, Krebsova, A, Clinical Genetics, MIBAVA Leducq Consortium, Goudot, Guillaume, University of Antwerp (UA), Centre de recherche du CHU Sainte-Justine / Research Center of the Sainte-Justine University Hospital [Montreal, Canada], Université de Montréal (UdeM)-CHU Sainte Justine [Montréal], The Jackson Laboratory [Bar Harbor] (JAX), Centre de Réféfence des Maladies Vasculaires Rares [HEGP, APHP] (CRMVR), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5), Karolinska Institutet [Stockholm], Karolinska University Hospital [Stockholm], University Medical Center of Schleswig–Holstein = Universitätsklinikum Schleswig-Holstein (UKSH), Kiel University, Radboud University Medical Center [Nijmegen], Howard Hughes Medical Institute (HHMI), Johns Hopkins University School of Medicine [Baltimore], and MIBAVA Leducq Consortium: Rustam Zhurayev, Dmytro Zerbino, Seema Mital, Luc Mertens, Anders Franco-Cereceda, Judith M A Verhagen, Ingrid M B H van de Laar, Marja W Wessels, Michaela Nemcikova, Alice Krebsova

Subjects
Adult, Heart Defects, Congenital, Male, Candidate gene, DNA Copy Number Variations, [SDV]Life Sciences [q-bio], Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Population, Heart Valve Diseases, Genome-wide association study, Disease, complex mixtures, Article, 03 medical and health sciences, Aortic aneurysm, All institutes and research themes of the Radboud University Medical Center, Bicuspid aortic valve, Bicuspid Aortic Valve Disease, Databases, Genetic, parasitic diseases, Genetics, medicine, Humans, Copy-number variation, education, Biology, Genetics (clinical), 0303 health sciences, education.field_of_study, Aortic Aneurysm, Thoracic, business.industry, 030305 genetics & heredity, Middle Aged, medicine.disease, Phenotype, digestive system diseases, [SDV] Life Sciences [q-bio], Chemistry, Aortic Valve, Female, Human medicine, T-Box Domain Proteins, business, Genome-Wide Association Study, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]
Abstract

International audience; Bicuspid aortic valve (BAV) is the most common congenital heart defect (CHD), affecting 1-2% of the population. BAV is associated with thoracic aortic aneurysms (TAAs). Deleterious copy number variations (CNVs) were found previously in up to 10% of CHD cases. This study aimed at unravelling the contribution of deleterious deletions or duplications in 95 unrelated BAV/TAA patients. Seven unique or rare CNVs were validated, harbouring protein-coding genes with a role in the cardiovascular system. Based on the presence of overlapping CNVs in patients with cardiovascular phenotypes in the DECIPHER database, the identification of similar CNVs in whole-exome sequencing data of 67 BAV/TAA patients and suggested topological domain involvement from Hi-C data, supportive evidence was obtained for two genes (DGCR6 and TBX20) of the seven initially validated CNVs. A rare variant burden analysis using next-generation sequencing data from 637 BAV/TAA patients was performed for these two candidate genes. This revealed a suggestive genetic role for TBX20 in BAV/TAA aetiology, further reinforced by segregation of a rare TBX20 variant with the phenotype within a BAV/TAA family. To conclude, our results do not confirm a significant contribution for deleterious CNVs in BAV/TAA as only one potentially pathogenic CNV (1.05%) was identified. We cannot exclude the possibility that BAV/TAA is occasionally attributed to causal CNVs though, or that certain CNVs act as genetic risk factors by creating a sensitised background for BAV/TAA. Finally, accumulative evidence for TBX20 involvement in BAV/TAA aetiology underlines the importance of this transcription factor in cardiovascular disease.

Published
2019
Full Text
View/download PDF

41. Takayasu Arteritis and Pregnancy

Author

Comarmond, C., Mirault, T., Biard, L., Nizard, J., Lambert, M., Wechsler, B., Hachulla, E., Chiche, L., Koskas, F., Gaudric, J., Cluzel, P., Messas, E., Resche-Rigon, M., Piette, J. C., Cacoub, P., and Saadoun, D.

Published
2015
Full Text
View/download PDF

44. 25 ans, 300 numéros !

Author

Artigou, J.-Y., primary, Aupetit, J.-F., additional, Blacher, J., additional, Carrié, D., additional, Desnos, M., additional, Douard, H., additional, Hagège, A.-A., additional, Isnard, R., additional, Lechat, P., additional, Leenhardt, A., additional, Léger, P., additional, Messas, E., additional, Metz, D., additional, Minvielle, F., additional, Monsuez, J.-J., additional, Rodriguez, D., additional, Roudaut, R., additional, and Salvatore, R., additional

Published
2021
Full Text
View/download PDF

45. 41P Testosterone level and severity of COVID-19 infection in ambispective cohorts: The TESTOVID study

Author

Noel, J., primary, Sabouret, A., additional, Auclin, E., additional, Arlet, J.B., additional, Hermann, B., additional, Diehl, J.L., additional, Hulot, J.S., additional, Messas, E., additional, Detriche, G., additional, Lebeaux, D., additional, Baron, S., additional, Blanchard, A., additional, Brabant, S., additional, Djobo, B., additional, Auvray-Kuentz, M., additional, Prie, D., additional, Laouenan, C., additional, Dorival, C., additional, Barale, J.C., additional, and Oudard, S.M., additional

Published
2021
Full Text
View/download PDF

46. Carotid plaque vulnerability assessed by Shear Wave elastography and ultrafast Doppler compared to histology: The UF-plaque study

Author

Goudot, G., primary, Sitruk, J., additional, Jimenez, A., additional, Khider, L., additional, Tanter, M., additional, Pedreira, O., additional, Bruneval, P., additional, Julia, P., additional, El Batti, S., additional, Alsac, J.M., additional, Calvet, D., additional, Mirault, T., additional, Pernot, M., additional, and Messas, E., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results